See more : ADDvise Group AB (publ) (ADDV-A.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Jupiter Life Line Hospitals Limited (JLHL.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jupiter Life Line Hospitals Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Vieworks Co., Ltd. (100120.KQ) Income Statement Analysis – Financial Results
- Quality Houses Leasehold Property Fund (QHPF.BK) Income Statement Analysis – Financial Results
- TK Group (Holdings) Limited (2283.HK) Income Statement Analysis – Financial Results
- UNITED LEASING & INDUSTRIES LT (UNTTEMI.BO) Income Statement Analysis – Financial Results
- PETRONAS Gas Berhad (PNAGF) Income Statement Analysis – Financial Results
Jupiter Life Line Hospitals Limited (JLHL.BO)
About Jupiter Life Line Hospitals Limited
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company provides treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, ENT, endocrinology and diabetes, gastroenterology, general surgery and minimal access surgery, HPB and surgical gastroenterology, hematology and BMT, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurgery, nutrition and dietetics, Obs and gynecology, oncology, ophthalmology, organ transplant, orthopedics, pediatrics, pain clinic, plastic and cosmetic surgery, rehabilitation, rheumatology, robotic knee replacement, and urology. It also operates breast care center, chest medicine, and pain clinic departments, as well as hotel under the Fortune Park Lake City Hotel name in Thane. The company was incorporated in 2002 and is based in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 10.70B | 8.93B | 7.33B | 4.86B | 4.63B |
| Cost of Revenue | 2.14B | 1.81B | 1.60B | 1.13B | 2.11B |
| Gross Profit | 8.55B | 7.11B | 5.73B | 3.74B | 2.52B |
| Gross Profit Ratio | 79.99% | 79.70% | 78.23% | 76.85% | 54.48% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.72B | 2.18B | 1.73B | 1.16B | 1.89B |
| Selling & Marketing | 7.53M | 35.32M | 45.76M | 9.85M | 14.70M |
| SG&A | 2.72B | 2.22B | 1.78B | 1.17B | 1.90B |
| Other Expenses | 5.83B | 10.94M | 8.91M | 7.97M | -34.27M |
| Operating Expenses | 8.55B | 5.48B | 4.55B | 3.35B | 1.94B |
| Cost & Expenses | 8.72B | 7.29B | 6.15B | 4.47B | 4.04B |
| Interest Income | 193.88M | 68.05M | 17.02M | 29.58M | 2.64M |
| Interest Expense | 263.41M | 387.44M | 366.54M | 314.63M | 256.87M |
| Depreciation & Amortization | 423.82M | 385.55M | 361.57M | 307.37M | 259.11M |
| EBITDA | 2.61B | 2.10B | 1.56B | 709.18M | 835.12M |
| EBITDA Ratio | 24.40% | 23.37% | 20.55% | 13.66% | 18.23% |
| Operating Income | 1.98B | 1.65B | 1.18B | 380.38M | 584.65M |
| Operating Income Ratio | 18.53% | 18.46% | 16.09% | 7.82% | 12.63% |
| Total Other Income/Expenses | -27.94M | -444.77M | -441.35M | -375.19M | -265.51M |
| Income Before Tax | 1.95B | 1.29B | 771.18M | 15.55M | 319.14M |
| Income Before Tax Ratio | 18.27% | 14.42% | 10.52% | 0.32% | 6.89% |
| Income Tax Expense | 188.03M | 558.03M | 259.90M | 38.52M | 32.56M |
| Net Income | 1.77B | 729.05M | 511.28M | -22.97M | 296.33M |
| Net Income Ratio | 16.51% | 8.17% | 6.97% | -0.47% | 6.40% |
| EPS | 28.68 | 12.90 | 9.05 | -0.41 | 5.24 |
| EPS Diluted | 28.68 | 12.90 | 9.05 | -0.41 | 5.24 |
| Weighted Avg Shares Out | 61.57M | 56.52M | 56.52M | 56.52M | 56.52M |
| Weighted Avg Shares Out (Dil) | 61.57M | 56.52M | 56.52M | 56.52M | 56.52M |
Source: https://incomestatements.info
Category: Stock Reports